A new Human Gut Microbiome Atlas is revolutionizing research on how gut microorganisms impact disease and treatment worldwide.
- A new Human Gut Microbiome Atlas has been developed to help researchers and healthcare professionals understand how gut microorganisms impact disease for more effective treatment.
- The international collaboration led by King’s College London identifies gut bacteria associated with 23 diseases across 19 countries, providing insight for diseases like colorectal cancer and Crohn’s Disease.
- The atlas aims to help diagnose diseases and tailor treatments based on microbiome patterns that are common across different illnesses.
- The study involved analyzing genetic data from over 6,000 human gut microbiome samples across various regions, using machine learning to classify prevalent gut bacteria in healthy individuals and those with specific diseases.
- In the future, the team plans to expand the work to produce oral and skin microbiome atlases to address illnesses like eczema and psoriasis, as well as combat antimicrobial resistance (AMR) in the gut.
Source link
Gastroenterology, Public Health & Prevention, Infectious Diseases, Microbiome